2015
Sample preparation for N-glycosylation analysis of therapeutic monoclonal antibodies by electrophoresis
SZEKRÉNYES, Ákos; Jan PARTYKA; Csaba VARADI; Jana KRENKOVA; František FORET et. al.Základní údaje
Originální název
Sample preparation for N-glycosylation analysis of therapeutic monoclonal antibodies by electrophoresis
Autoři
SZEKRÉNYES, Ákos (348 Maďarsko); Jan PARTYKA (203 Česká republika, domácí); Csaba VARADI (348 Maďarsko); Jana KRENKOVA (203 Česká republika); František FORET (203 Česká republika, garant, domácí) a András GUTTMAN (348 Maďarsko)
Vydání
NEW YORK, Methods in Molecular Biology, od s. 183-195, 13 s. Microchip Capillary Electrophoresis Protocols, 1274, 2015
Nakladatel
Springer Science+Business Media
Další údaje
Jazyk
angličtina
Typ výsledku
Kapitola resp. kapitoly v odborné knize
Obor
10406 Analytical chemistry
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Forma vydání
tištěná verze "print"
Odkazy
Kód RIV
RIV/00216224:14740/15:00082381
Organizační jednotka
Středoevropský technologický institut
ISBN
978-1-4939-2352-6
EID Scopus
2-s2.0-84922879525
Klíčová slova anglicky
capillary electrophoresis; monoclonal antibodies; sample preparation; Fluorophore labeling; N-glycan analysis; Therapeutic monoclonal antibody
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 29. 4. 2016 12:48, Mgr. Eva Špillingová
Anotace
V originále
There are a considerable number of biopharmaceuticals that have been approved for clinical use in the past decade. Over half of these new generation drugs are glycoproteins, such as monoclonal antibodies or other recombinant glycoproteins, which are mostly produced in mammalian cell lines. The linked carbohydrate moieties affect not only their physicochemical properties and thermal stability but also crucial features like receptor-binding activity, circulating half-life, as well as immunogenicity. The structural diversity of these attached glycans can be manifested in altered monosaccharide composition and linkages/positions among the monosaccharide building blocks. In addition, as more and more biosimilar products hit the market, understanding the effects of their glycosylation modification has become a recent target in efficacy and safety issues. To ensure consistent quality of these products, glycosylation profiles have to be monitored and controlled in all steps of the manufacturing process, i.e., from clone selection to lot release. In this paper, we describe some of the recently introduced and commonly used sample preparation techniques for capillary electrophoresis (CE)-based profiling and structural elucidation of N-glycans. The presented protocols include protein A affinity partitioning of monoclonal antibodies (mAbs), enzymatic release of the N-linked glycans, labeling of the liberated carbohydrates, reaction mixture purification techniques to remove the excess labeling reagent, and high-resolution and rapid capillary electrophoresis-laser-induced fluorescence (CE-LIF)-based profiling of the labeled and purified N-glycans.